Skye Bioscience (SKYE) Market Capitalization (2015 - 2026)

Skye Bioscience (SKYE) has reported Market Capitalization for 12 consecutive years, with $3.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Market Capitalization fell 85.37% year-over-year to $3.0 million in Q2 2026; TTM through Jun 2026 was $3.0 million, a 85.37% decrease from a year earlier, with the FY2025 full-year figure at $3.1 million, down 71.44% from the prior year.
• Market Capitalization was $3.0 million for Q2 2026 at Skye Bioscience, up from $2.7 million in the prior quarter.
• Over five years, Market Capitalization peaked at $54.9 million in Q1 2024 and troughed at $1.1 million in Q4 2022.
• A 5-year average of $11.0 million and a median of $3.1 million in 2025 frame the typical range for Market Capitalization.
• Across the five-year window, Market Capitalization soared 2557.39% in 2024 and slumped 85.64% in 2025, its largest moves.
• Over 5 years, Market Capitalization stood at $1.1 million in 2022, then jumped by 114.5% to $2.4 million in 2023, then jumped by 359.99% to $11.0 million in 2024, then tumbled by 71.44% to $3.1 million in 2025, then dropped by 3.13% to $3.0 million in 2026.
• The last three Market Capitalization figures came in at $3.0 million (Q2 2026), $2.7 million (Q1 2026), and $3.1 million (Q4 2025), per Business Quant data.